Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Bellerophon Therapeutics, Inc.Listing unverified | Sell | $146.5K | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Sell | $352.3K | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Sell | $25.3K | SEC | |
Anacor Pharmaceuticals, Inc.Listing unverified | Sell | $227.9K | SEC | |
Anacor Pharmaceuticals, Inc.Listing unverified | Sell | $67.6K | SEC | |
Anacor Pharmaceuticals, Inc.Listing unverified | Sell | $98.4K | SEC | |
ALIMERA SCIENCES INCListing unverified | Other | — | SEC | |
ALIMERA SCIENCES INCListing unverified | Other | — | SEC | |
Trubion Pharmaceuticals, IncListing unverified | OtherD (derivative) | — | SEC | |
Trubion Pharmaceuticals, IncListing unverified | Buy | $372.3K | SEC | |
Trubion Pharmaceuticals, IncListing unverified | Other | — | SEC |